PD-L1 expression and its significance in advanced NSCLC: real-world experience from a tertiary care center.
Sindhu KilaruSoumya Surath PandaLalatendu MoharanaDebahuti MohapatraSatya Sundar G MohapatraAdyakinkar PandaSpoorthy KolluriSuma DevarajGhanashyam BiswasPublished in: Journal of the Egyptian National Cancer Institute (2024)
Forty-five percent of advanced NSCLC patients in our cohort showed positive PD-L1 expression and it is associated with tobacco use and aggressive tumor characteristics.